Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,072.00    106.00 (5.39%)
Bid:
2,058.00
Ask:
2,072.00
Spread: 14.00 (0.68%)
Market Cap: £1.38b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

10 Sep 2010 14:00

RNS Number : 4952S
Genus PLC
10 September 2010
 

10 September 2010

FOR IMMEDIATE RELEASE 

 

 

GENUS plc

('Genus' or 'the Company')

 

Directors' and PDMRs' Share Options

 

Genus announces that conditional nil-cost share options were granted under the Genus 2004 Performance Share Plan ("the Plan") today to John Worby, Group Finance Director, as to 37,680 ordinary shares of 10 pence each in the Company ("Shares"), to Ian Biggs, Head of Global Product & Business Strategy, as to 27,404 Shares, to Thomas Philip Acton, Chief Operating Officer of Europe & The Far East as to 27,404 Shares, to Bill Christianson, Chief Operating Officer of The Americas, as to 24,418 Shares, to Ian Farrelly, Group Company Secretary & General Counsel as to 21,923 Shares and to David Crosby, Group Financial Controller, as to 19,457 Shares.

 

These options are subject to performance conditions which relate to growth in the Company's earnings per share over a three year period and which trigger vesting on an incremental basis.

 

John Worby's direct shareholding stands at 10,000 Shares representing 0.017% of the issued share capital of the Company. In addition, he is the beneficial owner of 166,220 nil-cost options. 

 

Ian Biggs' direct shareholding stands at 3,375 Shares representing 0.006% of the issued share capital of the Company. In addition, he is the beneficial owner of 143,894 conditional shares and nil-cost options. 

 

Thomas Philip Acton's direct shareholding stands at 21,104 Shares representing 0.035% of the issued share capital of the Company. In addition, he is the beneficial owner of 136,589 conditional shares and nil-cost options.

 

Bill Christianson has no direct shareholding in the Company and is the beneficial owner of 36,500 nil-cost share options and 34,693 market value share options.

 

Ian Farrelly has no direct shareholding in the Company and is the beneficial owner of 92,200 conditional shares and nil-cost share options.

 

David Crosby has no direct shareholding in the Company and is the beneficial owner of 38,861 nil-cost share options and 16,373 market value share options. 

 

 

For further information please contact:

 

Cara Crichton

Company Secretarial Assistant

Genus plc

 

Tel: 01256 345996

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSURORRRWAKAAR
Date   Source Headline
13th Aug 200910:36 amRNSNotice of Results
31st Jul 20092:00 pmRNSTotal Voting Rights
31st Jul 20092:00 pmRNSBlocklisting Return
15th Jul 20092:00 pmRNSHolding(s) in Company
9th Jul 20097:00 amRNSPre-Close Trading Update
1st Jun 20092:00 pmRNSTotal Voting Rights
20th May 20092:00 pmRNSDirector/PDMR Shareholding
18th May 20092:00 pmRNSDirector/PDMR Shareholding
7th May 20097:00 amRNSBoard Appointment
1st May 20097:00 amRNSInterim Management Statement
30th Apr 20092:00 pmRNSTotal Voting Rights
14th Apr 20092:00 pmRNSHolding(s) in Company
6th Apr 20092:00 pmRNSAppointment of Broker & Adviser
3rd Mar 20092:00 pmRNSDirector's Share Options
26th Feb 20097:00 amRNSBoard Update
26th Feb 20097:00 amRNSInterim Results
20th Feb 20097:00 amRNSBusiness Expansion in China
5th Feb 200910:17 amRNSNotice of Results
30th Jan 20092:30 pmRNSBlocklisting Six Monthly Return
30th Jan 20092:30 pmRNSTotal Voting Rights
5th Jan 20097:00 amRNSAppointment of Brokers & Advisers
31st Dec 200812:40 pmRNSSecond Price Monitoring Extn
31st Dec 200812:37 pmRNSPrice Monitoring Extension
8th Dec 20084:33 pmRNSDirector/PDMR Shareholding
14th Nov 20084:04 pmRNSHolding(s) in Company
13th Nov 20083:06 pmRNSResult of AGM
13th Nov 20087:00 amRNSAGM & Interim Management Statement
27th Oct 20082:00 pmRNSHolding(s) in Company
17th Oct 20082:00 pmRNSAnnual Information Update
15th Oct 20082:30 pmRNSDirector/PDMR Shareholding
15th Oct 20082:00 pmRNSBoard Update
8th Oct 20084:47 pmRNSDirector/PDMR Shareholding
7th Oct 20082:00 pmRNSHolding(s) in Company
30th Sep 20082:08 pmRNSBlocklisting Interim Review
30th Sep 20082:00 pmRNSTotal Voting Rights
19th Sep 20081:37 pmRNSDirector/PDMR Shareholding
18th Sep 20087:00 amRNSUpdate on Strategy - China
16th Sep 20087:00 amRNSPreliminary Results
31st Jul 20084:00 pmRNSTotal Voting Rights
25th Jul 20084:00 pmRNSBlocklisting Interim Review
16th Jul 20087:00 amRNSPre-Close Trading Update
14th Jul 20082:00 pmRNSHolding(s) in Company
30th Jun 20084:30 pmRNSTotal Voting Rights
30th May 20084:00 pmRNSTotal Voting Rights
28th May 200812:06 pmRNSMerger Update
19th May 20083:51 pmRNSDirector/PDMR Shareholding
14th May 20084:00 pmRNSMerger Update
30th Apr 20084:00 pmRNSTotal Voting Rights
29th Apr 20087:00 amRNSInterim Management Statement
10th Apr 20084:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.